The Problematic Economics of Integrative Oncology

2018 ◽  
Vol 24 (9-10) ◽  
pp. 1025-1027 ◽  
Author(s):  
Patricia M. Herman
Keyword(s):  
Pharmaceutics ◽  
2021 ◽  
Vol 13 (5) ◽  
pp. 626
Author(s):  
Elvin Peter Chizenga ◽  
Heidi Abrahamse

Good medicine is based on good science, inquiry driven and open to new paradigms. For a complex disease such as cancer, a complex treatment regime that is well structured and multifactorial is indispensable. In the present day, Complementary and Alternative Medicine (CAM) therapies are being used frequently for cancer, alongside modern biological therapies and allopathic medicine, in what is called integrative oncology. In all conscience, the use of natural, less invasive interventions whenever possible is ideal. However, a comprehensive understanding of not only the etiopathology of individual cancers, but also the detailed genetic and epigenetic characteristics, the cancer hallmarks, that clearly show the blueprint of the cancer phenotype is a requisite. Different tumors have a common behavioral pattern, but their specific features at the genetic and epigenetic levels vary to a great extent. Henceforth, with so many failed attempts to therapy, drug formulations and combinations need a focused pre-assessment of the inherent features of individual cancers to destroy the tumors holistically by targeting these features. This review therefore presents innocuous therapeutic regimes by means of CAM and integrative medicine approaches that can specifically target the hallmarks of cancer, using the case of cervical cancer.


2012 ◽  
Vol 18 (9) ◽  
pp. 643-651 ◽  
Author(s):  
Gustav J. Dobos ◽  
Barbara Kirschbaum ◽  
Kyung-Eun Choi

Author(s):  
Robert Knoerl ◽  
Carolyn S. Phillips ◽  
Juliana Berfield ◽  
Heather Woods ◽  
Meghan Acosta ◽  
...  

2017 ◽  
Vol 8 (3) ◽  
pp. 395-402 ◽  
Author(s):  
Gabriel Lopez ◽  
Jennifer McQuade ◽  
Lorenzo Cohen ◽  
Jane T Williams ◽  
Amy R Spelman ◽  
...  

2021 ◽  
Vol 20 ◽  
pp. 153473542110638
Author(s):  
Eun-Bin Kwag ◽  
Soo-Dam Kim ◽  
Ji Hye Park ◽  
So-Jung Park ◽  
Mi-Kyung Jeong ◽  
...  

Cancer is one of the leading causes of death worldwide, and Korea is no exception. Humanity has been fighting cancer for many years, and as a result, we now have effective treatments such as chemotherapy, radiation, and surgery. However, there are other issues that we are only now beginning to address, such as cancer patients’ quality of life. Moreover, numerous studies show that addressing these issues holistically is critical for overall cancer treatment and survival rates. This paper describes how Korea is attempting to reduce cancer incidence and recurrence rates while also managing the quality of life of cancer patients. Integrative Oncology is the field that addresses these broad issues, and understanding the current state of integrative oncology in Korea is critical. The goal of this paper is to provide an overview of the current state of integrative oncology in Korea as well as to look ahead to future developments.


Sign in / Sign up

Export Citation Format

Share Document